Illumina Investors
Illumina is a prominent venture capital fund based in San Diego, California, established in 1998 The firm specializes in investments within the life sciences sector, focusing on innovative technologies that enhance genomic research and healthcare With a significant investment scale of $96,000,000, Illumina actively supports early-stage companies that are poised to transform the landscape of genomics and personalized medicine The funds strategic approach emphasizes fostering advancements that align with its commitment to improving human health through cutting-edge science and technology
Acquisitions Number:
Made Acquisitions
Founded Date:
1998
Last Funding Type:
Post-IPO Debt
Headquarters:
USA
Investors Number:
19
Technology:
Neurological Disorders
Employee Number:
5001-10000
Industry:
FemTech
Estimated Revenue:
$500M to $1B
Last Funding Date:
2023-01-04
Number Of Exists:
6
Funding Status:
IPO
Investor Type:
Venture Capital Funds
Investment Stage:
Early Stage Venture, Late Stage Venture
Total Funding:
778000000.0